​

Psyence Biomedical Ownership | Who Owns Psyence Biomedical?

OverviewChart

Psyence Biomedical Ownership Summary

Psyence Biomedical is owned by 10.22% institutional investors, 4.45% insiders, and 85.34% retail investors. AdvisorShares Psychedelics ETF is the top mutual fund, with 2.43% of its assets in Psyence Biomedical shares.

PBM Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockPsyence Biomedical10.22%4.45%85.34%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20262-151,339-10-2---
Sep 30, 20241110.00%2,014,160122.21%1034.75%860.00%1-50.00%
Jun 30, 202410-906,41822.31%463.20%5-50.00%2-
Mar 31, 202410-741,092-38-10---

Top Mutual Funds Shareholders

HolderShares% HoldingChange
AdvisorShares Psychedelics ETF55.66K2.43%850.00

PBM Ownership FAQ

Who Owns Psyence Biomedical?

Psyence Biomedical shareholders are primarily institutional investors at 10.22%, followed by 4.45% insiders and 85.33% retail investors. The average institutional ownership in Psyence Biomedical's industry, Biotech Stocks , is 35.75%, which Psyence Biomedical falls below.

Does Blackrock own Psyence Biomedical?

BlackRock is not among the top 10 institutional shareholders of Psyence Biomedical.

Who is the top mutual fund holder of Psyence Biomedical shares?

AdvisorShares Psychedelics ETF is the top mutual fund holder of Psyence Biomedical shares, with 2.43% of its total shares outstanding invested in 55.66K Psyence Biomedical shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools